NCT02888743 2026-03-19
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Sun Yat-sen University
Blokhin's Russian Cancer Research Center
Memorial Sloan Kettering Cancer Center